BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15584083)

  • 1. Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography/mass spectrometry with scan-to-scan polarity switching.
    Deventer K; Van Eenoo P; Delbeke FT
    Rapid Commun Mass Spectrom; 2005; 19(2):90-8. PubMed ID: 15584083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry.
    Deventer K; Delbeke FT; Roels K; Van Eenoo P
    Biomed Chromatogr; 2002 Dec; 16(8):529-35. PubMed ID: 12474217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous extraction and screening of diuretics, beta-blockers, selected stimulants and steroids in human urine by HPLC-MS/MS and UPLC-MS/MS.
    Murray GJ; Danaceau JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3857-64. PubMed ID: 19837636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and application of a screening method for beta2-agonists, anti-estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry.
    Kang MJ; Hwang YH; Lee W; Kim DH
    Rapid Commun Mass Spectrom; 2007; 21(2):252-64. PubMed ID: 17171780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Xipamide metabolite in human urine by high-performance liquid chromatography/diode-array detection, high-performance liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry.
    Kim Y; Han K; Paeng KJ
    Rapid Commun Mass Spectrom; 2004; 18(20):2505-12. PubMed ID: 15384135
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation of a screening method for corticosteroids in doping analysis by liquid chromatography/tandem mass spectrometry.
    Deventer K; Delbeke FT
    Rapid Commun Mass Spectrom; 2003; 17(18):2107-14. PubMed ID: 12955741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
    Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
    J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry.
    Deventer K; Eenoo PV; Delbeke FT
    Biomed Chromatogr; 2006 May; 20(5):429-33. PubMed ID: 16177960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control.
    Girón AJ; Deventer K; Roels K; Van Eenoo P
    Anal Chim Acta; 2012 Apr; 721():137-46. PubMed ID: 22405312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
    Kolmonen M; Leinonen A; Pelander A; Ojanperä I
    Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast gas chromatographic/mass spectrometric determination of diuretics and masking agents in human urine: Development and validation of a productive screening protocol for antidoping analysis.
    Morra V; Davit P; Capra P; Vincenti M; Di Stilo A; Botrè F
    J Chromatogr A; 2006 Dec; 1135(2):219-29. PubMed ID: 17027009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids.
    Georgakopoulos CG; Vonaparti A; Stamou M; Kiousi P; Lyris E; Angelis YS; Tsoupras G; Wuest B; Nielen MW; Panderi I; Koupparis M
    Rapid Commun Mass Spectrom; 2007; 21(15):2439-46. PubMed ID: 17610244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: comparison between liquid-liquid extraction and direct injection.
    Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
    J Chromatogr A; 2009 Jul; 1216(31):5819-27. PubMed ID: 19560151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS/MS.
    Thörngren JO; Ostervall F; Garle M
    J Mass Spectrom; 2008 Jul; 43(7):980-92. PubMed ID: 18576434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis.
    Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
    Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents.
    Ventura R; Roig M; Montfort N; Sáez P; Bergés R; Segura J
    Eur J Mass Spectrom (Chichester); 2008; 14(3):191-200. PubMed ID: 18708699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Wrong-way-round ionization' and screening for doping substances in human urine by high-performance liquid chromatography/orbitrap mass spectrometry.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2012 Mar; 47(3):381-91. PubMed ID: 22431466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for amphetamine and amphetamine-type drugs in doping analysis by liquid chromatography/mass spectrometry.
    Deventer K; Van Eenoo P; Delbeke FT
    Rapid Commun Mass Spectrom; 2006; 20(5):877-82. PubMed ID: 16470715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.